LPCN Earnings

Quarterly EPS
$-0.41
Q3 2024
$0.33
Q4 2024
$-0.35
Q1 2025
$-0.41
Q2 2025
$-0.59
Q3 2025
$-0.42
Q4 2025
$-0.54
Q1 2026
$-0.32
Q2 2026
Latest RevenueN/A
Latest Net Income-2622595
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.320-2622595-100.0%+22.0%
Q1 2026-$0.540-3671894-54.3%
Q4 2025-$0.421.1M-2370084-67.2%-227.3%
Q3 2025-$0.59114.6K-3186832-43.9%
Q2 2025-$0.41500.0K-2205716+458.3%+28.1%
Q1 2025-$0.350-1864873-100.0%-153.0%
Q4 2024$0.333.5M1.8M+1,515.0%+176.7%
Q3 2024-$0.410-2218818+100.0%+67.5%
Q2 2024-$0.5789.6K-3068634
Q1 2024$0.667.6M3.5M
Q4 2023-$0.43216.2K-2282253
Q3 2023-$1.26-3121996-6650970
Lipocine (LPCN) — Earnings